MED

$0.00

(

+0.00%

)
Quote details

stock

MEDIFAST INC

NYSE | MED

13.19

USD

+0.00

(

+0.00%

)

AT CLOSE (AS OF Aug 15, 2025)

$143M

MARKET CAP

39.48

P/E Ratio

0.33

EPS

$22

52 Week High

$12

52 Week Low

MANUFACTURING

Sector

MED Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback's Trading Journal

MED Technicals

Tags:

MED Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $445M
Total Revenue $602M
Cost Of Revenue $158M
Costof Goods And Services Sold $158M
Operating Income $2.9M
Selling General And Administrative $442M
Research And Development -
Operating Expenses $442M
Investment Income Net -
Net Interest Income $4.8M
Interest Income $4.8M
Interest Expense $4.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax $3.8M
Income Tax Expense $1.7M
Interest And Debt Expense -
Net Income From Continuing Operations $2.1M
Comprehensive Income Net Of Tax -
Ebit $2.9M
Ebitda $16M
Net Income $2.1M

Revenue & Profitability

Earnings Performance

MED Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $284M
Total Current Assets $214M
Cash And Cash Equivalents At Carrying Value $91M
Cash And Short Term Investments $91M
Inventory $42M
Current Net Receivables -
Total Non Current Assets $70M
Property Plant Equipment $49M
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $71M
Other Current Assets $9.6M
Other Non Current Assets -
Total Liabilities $74M
Total Current Liabilities $64M
Current Accounts Payable $23M
Deferred Revenue -
Current Debt -
Short Term Debt $6.2M
Total Non Current Liabilities $9.9M
Capital Lease Obligations $16M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $16M
Other Current Liabilities $33M
Other Non Current Liabilities -
Total Shareholder Equity $210M
Treasury Stock -
Retained Earnings $177M
Common Stock $11K
Common Stock Shares Outstanding $11M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $24M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $17M
Capital Expenditures $7.5M
Change In Receivables -
Change In Inventory $12M
Profit Loss -
Cashflow From Investment -$27M
Cashflow From Financing -$1.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $715K
Dividend Payout Common Stock $715K
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$836K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $2.1M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $445M
Total Revenue $602M
Cost Of Revenue $158M
Costof Goods And Services Sold $158M
Operating Income $2.9M
Selling General And Administrative $442M
Research And Development -
Operating Expenses $442M
Investment Income Net -
Net Interest Income $4.8M
Interest Income $4.8M
Interest Expense $4.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax $3.8M
Income Tax Expense $1.7M
Interest And Debt Expense -
Net Income From Continuing Operations $2.1M
Comprehensive Income Net Of Tax -
Ebit $2.9M
Ebitda $16M
Net Income $2.1M

Dividends

Field Value
Ex Dividend Date 2023-09-18
Declaration Date 2023-09-07
Record Date 2023-09-19
Payment Date 2023-11-07
Amount 1.65

MED News

MED Profile

MEDIFAST INC Profile

Sector: MANUFACTURING

Industry: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS

Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.

Discover more tools and features to empower your trading
Explore Features

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.